Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: A 2015 perspective

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 968-971

  Sachs, Amy ^a,b   Blanchard, Leah ^a,b   Buchanan, Amanda ^a   Norwitz, Errol ^a,b   Bianchi, Diana W ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

47,XXX SYNDROME; 47,XYY SYNDROME; ANEUPLOIDY; ARTICLE; CHROMOSOME 21; CLINICAL FEATURE; DNA DETERMINATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; KARYOTYPE 47,XXY; MONOSOMY X; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TESTING; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; COUNSELING; FEMALE; MATERNAL SERUM SCREENING TEST; PREGNANCY; PROCEDURES;

COUNSELING; FEMALE; GENETIC COUNSELING; HUMANS; MATERNAL SERUM SCREENING TESTS; PREGNANCY;

EID: 84943226101     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4666     Document Type: Article

References (38)

1. Bianchi DW. Prepare for unexpected prenatal test results. Nature 2015;522:29-30.
2. Minear MA, Lewis C, Pradhan S, Chandrasekharan S. Global perspectives on clinical adoption of NIPT. Prenat Diagn 2015;35(10):959-67, 10.1002/pd.4637.
3. Agarwal A, Sayres LC, Cho MK, et al. Commercial landscape of noninvasive prenatal testing in the United States. Prenat Diagn 2013;33:521-31.
4. ACOG. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. Obstet Gynecol 2012;120:1532-4.
5. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-8.
6. Benn P, Borell A, Chiu R, et al. Position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenat Diagn 2013;33:622-9.
7. Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. J Genet Counsel 2013;22:291-5.
8. Skirton H, Goldsmith L, Jackson L, Lewis C, Chitty L. Offering prenatal diagnostic tests: European guidelines for clinical practice. Eur J Hum Genet 2014;22:580-6.
9. Buchanan A, Sachs A, Toler T, Tsipis J. NIPT: current utilization and implications for the future of prenatal genetic counseling. Prenat Diagn 2014;34:850-7.
10. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799-808.
11. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589-97.
12. Helfgott A, and ABOG-SMFM Distinguished Lecture Series. SMFM statement: maternal serum cell-free DNA screening in low risk women. [WWW document]. URL https://www.smfm.org/publications/157-smfm-statement-maternal-serum-cell-free-dna-screening-in-low-risk-women. [accessed on 18 April 2015].
13. Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015;212:332.e1-9.
14. Allyse M, Minear MA, Berson E, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113-26.
15. Vora NL, O'Brien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014;123:1097-9.
16. del Mar Gil M, Quezada MS, Bregant B, et al. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther 2014;35:204.
17. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32:730.
18. Huang X, Zheng J, Chen M, et al. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014;34:335.
19. Benn P, Cuckle H, Pergament E. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:1270.
20. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
21. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-8.
22. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
23. Nicolaides KH, Syngelaki A, Gil M, et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X and Y. Prenat Diagn 2013;33:575-9.
24. Mazloom AR, Džakula Ž, Oeth P, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013;33:591-7.
25. Samango-Sprouse C, Banjevic M, Ryan A, et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013;33:643-9.
26. Nicolaides KH, Musci TJ, Struble CA, et al. Assessment of fetal sex aneuploidy using directed cell-free DNA analysis. Fetal Diagn Ther 2014;35:1-6.
27. Dugo N, Padula F, Mobili L, et al. Six consecutive false positive cases from cell-free DNA testing in a single referring centre. J Prenat Med 2014;8:31-5.
28. Hall AL, Drendel HM, Verbrugge JL, et al. Positive cell-free DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med 2013;15:729-32.
29. Pan M, Li FT, Jiang FM, et al. Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:598-601.
30. Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from non-invasive prenatal testing for common aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 2013;33:602-8.
31. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251-9.
32. Yao H, Zhang L, Zhang H, et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn 2012;32:1114-6.
33. Snyder MW, Simmons LE, Kitzman JO, et al. Copy-number variation and false positive prenatal aneuploidy screening results. N Engl J Med 2015;372:1639-45.
34. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11.
35. Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015;314:162-9.
36. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74.
37. Curnow KJ, Wilkins-Haug L, Ryan A, et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015;212:79.e1-9.
38. Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med 2015;17:234-6.